Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytosorbents Corp (NASDAQ:CTSO)

4.33
Delayed Data
As of 12:48pm ET
 -0.12 / -2.70%
Today’s Change
3.11
Today|||52-Week Range
8.19
-22.26%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$112.6M

Company Description

CytoSorbents Corp. is a development stage critical care focused company using blood purification to treat life-threatening illnesses. Its technology is based upon biocompatible, porous polymer sorbent beads that are capable of extracting unwanted substances, such as drugs, dangerous chemicals, toxins, cytokines, free hemoglobin, and antibodies, from blood and other bodily fluids. The company was founded on April 25, 2002 and is headquartered in Monmouth Junction, NJ.

Contact Information

CytoSorbents Corp.
7 Deer Park Drive
Monmouth Junction New Jersey 08852
P:(732) 329-8885
Investor Relations:
17323298885825

Employees

Shareholders

Individual stakeholders24.36%
Mutual fund holders2.76%
Other institutional2.62%

Top Executives

Phillip P. ChanPresident, Chief Executive Officer & Director
Vincent CapponiChief Operating Officer
Kathleen P. BlochChief Financial Officer & Secretary
Robert Hawes BartlettChief Medical Officer
Steven SiskDirector-Clinical Operations